Delivery Order SPE2DX22D0010-SPE2D825FHP95
- Not listed
- The Defense Logistics Agency awarded a $1,218.07 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xtampza ER 27 mg capsules (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,061.58 firm fixed price delivery order is for the supply of 4,564,085,587 units of the prescription medication Xtampza ER 27 mg capsules. The contract has a period of performance through March 27, 2024 and does not have a set-aside designation. Amerisourcebergen...
- This is a $3,534.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xtampza ER 36 mg capsules, a prescription pain medication, with a period of performance through June 2025. The award is not set aside and was made through open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $250,750 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 100 capsules of the 18 mg dosage of XTAMPZA ER. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The one-day order is scheduled to be completed between September 28 and 29, 2023. No additional details were provided regarding the original...
- The Defense Logistics Agency awarded a $1,290.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 9 mg capsules (100-count units) with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- This is a Delivery Order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,417.36 firm fixed-price contract is for the supply of Xtampza ER Capsules 36mg, a specialty medication used for pain management. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,030.78, is for the delivery of XTAMPZA ER 27 MG CAPSULE 100S, a prescription medication. The contract is a Firm Fixed Price (FFP) delivery order, with a period of performance through May 2, 2024. This contract award is not associated with a set-aside program,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,092.43, is for the supply of the pharmaceutical product Xtampza ER 27 mg capsule, 100 count. The contract has a period of performance through March 14, 2025 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a firm fixed price delivery order valued at one hundred thirty-four dollars and five cents ($134.05) by the Defense Logistics Agency Troop Support Medical to supply one hundred (100) capsules of the pharmaceutical XTAMPZA ER 9 MG. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August 28 through 29, 2023. The Defense Logistics Agency Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.68 fixed-price delivery order contract is for the supply of XTAMPZA ER 9 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHP95Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,804.59 to AmerisourceBergen Drug Corp on August 12, 2025, for Xtampza ER Caps 27mg, a controlled-release opioid medication. This firm fixed-price delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation, and the place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies comprehensive medical commodities to military and veteran healthcare systems. Through its expansive DLA prime vendor contract, the company delivers an extensive portfolio of pharmaceuticals and medical supplies—including specialty medications, vaccines, generic and brand-name drugs, and medical devices—to support Defense Health Agency operations and other federal healthcare systems globally. This particular delivery order exemplifies AmerisourceBergen's role as a trusted pharmaceutical supplier for federal pain management and specialist medication needs within the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/12/25 |